CD39


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
03 02 2021
Historique:
received: 16 10 2020
accepted: 09 01 2021
entrez: 4 2 2021
pubmed: 5 2 2021
medline: 23 2 2021
Statut: epublish

Résumé

Some breast tumors metastasize aggressively whereas others remain dormant for years. The mechanism governing metastatic dormancy remains largely unknown. Through high-parametric single-cell mapping in mice, we identify a discrete population of CD39

Identifiants

pubmed: 33536445
doi: 10.1038/s41467-021-21045-2
pii: 10.1038/s41467-021-21045-2
pmc: PMC7859213
doi:

Substances chimiques

Antigens, CD 0
Programmed Cell Death 1 Receptor 0
Apyrase EC 3.6.1.5
CD39 antigen EC 3.6.1.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

769

Références

Nat Protoc. 2014 Jan;9(1):171-81
pubmed: 24385147
Nat Commun. 2017 Apr 06;8:14825
pubmed: 28382969
JCI Insight. 2019 Oct 3;4(19):
pubmed: 31465302
Nat Protoc. 2019 Feb;14(2):482-517
pubmed: 30664679
J Pathol. 2012 Jun;227(2):234-44
pubmed: 22262199
Cancer Discov. 2017 Feb;7(2):177-187
pubmed: 27974414
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nature. 2015 Dec 17;528(7582):413-7
pubmed: 26649828
Science. 2018 Sep 28;361(6409):
pubmed: 30262472
Nature. 2018 May;557(7706):575-579
pubmed: 29769722
Nature. 2019 Jul;571(7764):270-274
pubmed: 31207604
Methods Mol Biol. 2018;1845:71-86
pubmed: 30141008
Nat Rev Cancer. 2007 Nov;7(11):834-46
pubmed: 17957189
Clin Cancer Res. 2011 May 1;17(9):2967-76
pubmed: 21415211
Nature. 2007 Dec 6;450(7171):903-7
pubmed: 18026089
Annu Rev Immunol. 2019 Apr 26;37:457-495
pubmed: 30676822
Nat Rev Cancer. 2015 Apr;15(4):238-47
pubmed: 25801619
Nat Med. 2018 Jul;24(7):986-993
pubmed: 29942092
Cell. 2016 Mar 24;165(1):45-60
pubmed: 27015306
Cancer Res. 2013 Mar 15;73(6):1721-32
pubmed: 23345161
Cell Signal. 2013 Apr;25(4):961-9
pubmed: 23333246
Proc Natl Acad Sci U S A. 2010 Dec 14;107(50):21248-55
pubmed: 21081700
Nat Cell Biol. 2017 Aug;19(8):974-987
pubmed: 28737771
Curr Protoc Immunol. 2001 May;Chapter 20:Unit 20.2
pubmed: 18432775
Ann Oncol. 2014 Aug;25(8):1536-43
pubmed: 24915873
J Exp Med. 2019 Sep 2;216(9):2128-2149
pubmed: 31227543
N Engl J Med. 2005 Aug 25;353(8):793-802
pubmed: 16120859
Nat Commun. 2018 Jul 13;9(1):2724
pubmed: 30006565
Cancer Discov. 2019 Dec;9(12):1754-1773
pubmed: 31699796
Nat Cell Biol. 2013 Nov;15(11):1351-61
pubmed: 24161934
Cytometry A. 2016 Dec;89(12):1084-1096
pubmed: 27992111
Nat Med. 2018 Feb;24(2):144-153
pubmed: 29309059
J Clin Invest. 2010 Jun;120(6):2030-9
pubmed: 20501944
BMC Bioinformatics. 2016 Jun 02;17(1):228
pubmed: 27255077
Nat Biotechnol. 2013 Jun;31(6):539-44
pubmed: 23609047
Immunol Rev. 2018 May;283(1):161-175
pubmed: 29664565
J Immunol. 2015 Jun 1;194(11):5529-38
pubmed: 25911761
Cancer Immunol Res. 2020 Mar;8(3):356-367
pubmed: 31992567
N Engl J Med. 2017 Nov 9;377(19):1836-1846
pubmed: 29117498
Nat Commun. 2018 Oct 16;9(1):4297
pubmed: 30327458
Nat Cell Biol. 2019 Feb;21(2):238-250
pubmed: 30664790
Cytometry A. 2015 Jul;87(7):636-45
pubmed: 25573116
J Immunol. 2007 Feb 15;178(4):2132-40
pubmed: 17277117
Cell. 1994 Oct 21;79(2):315-28
pubmed: 7525077
Cancer Discov. 2016 Jun;6(6):630-49
pubmed: 27072748
Sci Immunol. 2017 Jan 6;2(7):
pubmed: 28783666
Nat Protoc. 2019 Jul;14(7):1946-1969
pubmed: 31160786
Nat Commun. 2019 Jun 3;10(1):2387
pubmed: 31160572
Immunity. 2016 May 17;44(5):989-1004
pubmed: 27192565
Breast Cancer Res Treat. 1996;41(2):177-85
pubmed: 8944336
J Immunol. 2004 May 1;172(9):5450-5
pubmed: 15100286
Nat Commun. 2016 Feb 17;7:10501
pubmed: 26883990
Br J Cancer. 2014 Mar 4;110(5):1378-84
pubmed: 24434426
Science. 2018 Jun 15;360(6394):
pubmed: 29773669
Cell. 2019 May 16;177(5):1330-1345.e18
pubmed: 30982598
Nat Rev Immunol. 2019 Nov;19(11):665-674
pubmed: 31570879
Proc Natl Acad Sci U S A. 2019 Oct 22;116(43):21704-21714
pubmed: 31591235
Nat Cell Biol. 2018 Nov;20(11):1240-1249
pubmed: 30361702
Nat Cell Biol. 2013 Jul;15(7):807-17
pubmed: 23728425
JCI Insight. 2018 May 17;3(10):
pubmed: 29769439
Nat Rev Cancer. 2014 Sep;14(9):611-22
pubmed: 25118602
Cancer Res. 1992 Mar 15;52(6):1399-405
pubmed: 1540948
Cancer Res. 2018 Jan 1;78(1):115-128
pubmed: 29066514
Nature. 2019 Mar;567(7749):540-544
pubmed: 30867597
Cell Rep. 2017 Apr 25;19(4):774-784
pubmed: 28445728
Nat Commun. 2019 Sep 27;10(1):4401
pubmed: 31562311
Cancer Res. 2006 Feb 1;66(3):1702-11
pubmed: 16452230
Nat Rev Cancer. 2017 May;17(5):302-317
pubmed: 28303905
Nature. 2013 Feb 21;494(7437):361-5
pubmed: 23376950
Nat Med. 2015 Jul;21(7):688-97
pubmed: 26121195
Proc Natl Acad Sci U S A. 2004 Nov 30;101(48):16885-90
pubmed: 15548615
Nat Commun. 2017 Apr 06;8:14979
pubmed: 28382931
J Natl Cancer Inst. 1999 Jan 6;91(1):80-5
pubmed: 9890174
Nat Cell Biol. 2015 Jun;17(6):816-26
pubmed: 25985394

Auteurs

Paulino Tallón de Lara (P)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.
Department of Medicine, Mount Sinai St. Luke's & Mount Sinai West, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Héctor Castañón (H)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.

Marijne Vermeer (M)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.

Nicolás Núñez (N)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.

Karina Silina (K)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.

Bettina Sobottka (B)

Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.

Joaquín Urdinez (J)

Department of Orthopaedics, Balgrist University Hospital, University of Zurich, Zurich, Switzerland.
Cutiss AG, Schlieren, Switzerland.

Virginia Cecconi (V)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.

Hideo Yagita (H)

Department of Immunology, Juntendo University School of Medicine, Tokyo, Japan.

Farkhondeh Movahedian Attar (F)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.

Stefanie Hiltbrunner (S)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.
Department of Hematology and Oncology, University Hospital Zurich, Zurich, Switzerland.

Isabelle Glarner (I)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.

Holger Moch (H)

Comprehensive Cancer Center Zurich, Zurich, Switzerland.
Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.

Sònia Tugues (S)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.

Burkhard Becher (B)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland.
Comprehensive Cancer Center Zurich, Zurich, Switzerland.

Maries van den Broek (M)

Institute of Experimental Immunology, University of Zurich, Zurich, Switzerland. vandenbroek@immunology.uzh.ch.
Comprehensive Cancer Center Zurich, Zurich, Switzerland. vandenbroek@immunology.uzh.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH